You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
青海春天(600381.SH):擬9500萬元受讓關聯方六中藥MAH和生產技術及資料
格隆匯 06-22 18:26

格隆匯6月22日丨青海春天(600381.SH)公佈,公司擬以人民幣9500萬元的總價格受讓關聯方三普藥業擁有的蟲草參芪膏(國藥準字B20020874)、蟲草參芪口服液(國藥準字B20020873)、利肺片(國藥準字Z20013185)、蟲草五味顆粒(國藥準字B20020850)、健腎益肺顆粒(國藥準字Z20026345)、健腎益肺口服液(國藥準字Z20026448)等六種中藥產品的上市許可持有人和有關生產技術及資料。

公司表示,此次交易如能完成,公司冬蟲夏草類產品資源的配置將更加合理,冬蟲夏草類產品線將更趨豐富、完整,大健康板塊的業務和盈利能力也將得到進一步的加強。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account